House of Commons of Canada Health Committee

House of Commons of Canada Health Committee
Name	Standing Committee on Health
Native name	Comité permanent de la santé
Formation	1994
Jurisdiction	House of Commons of Canada
Chamber	House of Commons
Parent organization	Parliament of Canada

House of Commons of Canada Health Committee

The Standing Committee on Health is a permanent legislative committee of the House of Commons of Canada that examines issues related to Health Canada, Canada Health Act, Public Health Agency of Canada, and a broad array of federal health portfolios. It conducts studies, holds hearings, and produces reports influencing legislation, interacting with institutions such as Canadian Institutes of Health Research, Health Standards Organization, Patented Medicine Prices Review Board, and stakeholders including Canadian Medical Association, Canadian Nurses Association, Canadian Pharmacists Association, and provincial ministries like Ministry of Health (Ontario). The committee’s work intersects with national events and actors including COVID-19 pandemic in Canada, SARS outbreak, H1N1 influenza pandemic, Tobacco Act, and partnerships with organizations such as World Health Organization, Pan American Health Organization, and Canadian Blood Services.

Mandate and Jurisdiction

The committee’s mandate covers federal statutes and entities such as Health Canada, Public Health Agency of Canada, Canadian Food Inspection Agency (for health-related matters), Canadian Institutes of Health Research, and program areas under the Canada Health Act. It examines legislative initiatives including amendments to the Food and Drugs Act, reviews spending estimates tied to the Department of Health, and oversees crown corporations like Canadian Blood Services and agencies such as the Patented Medicine Prices Review Board. Jurisdictional overlaps bring testimony from provincial actors like Ministry of Health (British Columbia), Ministry of Health and Long-Term Care (Ontario), and national bodies including Canadian Institute for Health Information.

Membership and Leadership

Membership comprises MPs from parties represented in the House of Commons of Canada including Liberal Party of Canada, Conservative Party of Canada, New Democratic Party, and sometimes members from the Bloc Québécois and the Green Party of Canada. Chairs have included parliamentarians who worked with institutions such as Canadian Medical Association and Royal College of Physicians and Surgeons of Canada. Leadership changes reflect parliamentary dynamics seen in events like the 2015 Canadian federal election and the 2019 Canadian federal election. Clerks and analysts supporting the committee liaise with parliamentary offices such as the Library of Parliament and the Office of the Speaker of the House of Commons.

Roles and Activities

The committee conducts roles including policy review, legislative scrutiny, and oversight, drawing witnesses from entities like Royal College of Physicians and Surgeons of Canada, Canadian Dental Association, Canadian Psychological Association, Canadian Cancer Society, and researchers from University of Toronto, McGill University, University of British Columbia, McMaster University, and University of Alberta. It holds public hearings involving stakeholders such as Patients' Rights Advocate groups and regulators like the National Advisory Committee on Immunization and agencies responding to crises such as the Vancouver Coastal Health response teams. Activities include pre-budget consultations with the Department of Finance Canada, and collaboration with the Senate of Canada committees on complementary subjects.

Key Studies and Reports

The committee has produced influential studies on subjects including pandemic preparedness following the SARS epidemic in Canada, opioid crises linked to the Canadian Centre on Substance Use and Addiction, medical assistance in dying in light of the Carter v Canada (Attorney General) jurisprudence, and access to medicines involving pharmaceutical firms such as Pfizer and Novartis during patent discussions with the Patented Medicine Prices Review Board. Reports often recommend action to ministers including the Minister of Health (Canada), and engage with institutions like Canadian Institutes of Health Research and organizations such as Heart and Stroke Foundation of Canada and Alzheimer Society of Canada.

Procedure and Operations

The committee operates under the Standing Orders of the House of Commons of Canada, scheduling sittings in rooms like those used by other standing committees, summoning witnesses including deputy ministers from Health Canada and officials from the Public Health Agency of Canada. It produces minutes and evidence managed by procedural staff from the Clerk of the House of Commons and consults legislative counsel from the Department of Justice (Canada) on statutory amendments. Committees may travel to provincial jurisdictions (e.g., Manitoba, Quebec) for in-person hearings and engage with international counterparts such as the United States Congress health-related committees and the European Parliament health committees for comparative study.

History and Evolution

Formed amid restructurings of Commons committees, the Health Committee evolved with public health milestones like the HIV/AIDS crisis in Canada, the implementation of the Canada Health Act (1984), and legal precedents such as R v Morgentaler. Its work intensified after national emergencies like the 2003 SARS outbreak and the COVID-19 pandemic, prompting collaboration with agencies including the Public Health Agency of Canada and research networks at CIHR. The committee’s remit and procedure have been reshaped by parliamentary reforms and political changes involving actors from the Privy Council Office and shifting priorities following federal budgets presented by Minister of Finance (Canada).

Impact on Health Policy

Through hearings, recommendations, and reports, the committee has influenced legislation and programs administered by Health Canada, guided funding decisions affecting institutions like Canadian Institutes of Health Research, and pressured regulators such as the Patented Medicine Prices Review Board and pharmaceutical companies including Merck and GlaxoSmithKline. Its investigations into public health crises contributed to policy shifts at provincial agencies like Alberta Health Services and national responses coordinated with the Public Health Agency of Canada and international organizations such as the World Health Organization. The committee’s work informs MPs, shapes ministerial action by figures such as the Minister of Health (Canada), and intersects with major legal, clinical, and institutional actors across Canada.

Category:Parliament of Canada committees